来自官方财务报表的收入、利润与现金流历史。
Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan, Europe, Switzerland, the United States, and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. It offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases; health food ingredients, preservatives, protein preparations, and supplements. The company in the Strategic Partnership with Atthena Therapeutics, Inc.
| 利润表 | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| 总收入 | JPY 170.8B | JPY 160.2B | JPY 148.3B | JPY 144.2B |
| 毛利 | JPY 113.3B | JPY 109.1B | JPY 98.0B | JPY 88.2B |
| 营业利润（EBIT） | JPY 35.5B | JPY 35.5B | JPY 33.3B | JPY 30.1B |
| 净利 | JPY 29.7B | JPY 32.6B | JPY 25.9B | JPY 22.8B |
来源：公司公开报告（SEC）。在依赖任何数字前请核对 SEC EDGAR。
资产负债表、现金流、季度数据与完整财务比率见 4516 交互式查看器。 /companies/us/4516
本网站信息仅用于教育与参考，不构成投资建议。不发布目标价或买卖建议。
About TickerBase · Data methodology & sources · Privacy · Terms